fda_approval · anda · info

TEVA PHARMS INC — ANDA approval: NILOTINIB HYDROCHLORIDE (unspecified)

Event date
2026-06-26 00:00:00Z
Observed
2026-07-09 22:53:28Z
Source ID
ANDA219134-1
Payload hash
1fa963edb32efc16064191e5

Summary

TEVA PHARMS INC received ANDA approval for NILOTINIB HYDROCHLORIDE (unspecified) on 2026-06-26. Dosage form: CAPSULE. Application #: ANDA219134.

Informational only. Not legal, financial, or medical advice.